Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-006241
Filing Date
2020-05-18
Accepted
2020-05-18 16:51:57
Documents
1
Period of Report
2020-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3251
  Complete submission text file 0001179110-20-006241.txt   4666
Mailing Address C/O IDM PHARMA, INC. 9 PARKER, SUITE 100 IRVINE CA 92618
Business Address
SHERMAN JEFFREY W (Reporting) CIK: 0001230482 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37569 | Film No.: 20890340

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Issuer) CIK: 0001634432 (see all company filings)

EIN.: 981130690 | State of Incorp.: L2
SIC: 2834 Pharmaceutical Preparations